IBSRELA
Active substance: tenapanor
TABLET · TENAPANOR HYDROCHLORIDE 53.2 mg/1
United StatesActive
Marketing holder: Ardelyx, Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- TENAPANOR HYDROCHLORIDE · 53.2 mg/1
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-2ea8-7440-a823-7022e6a1d236,01a1208c-2ea9-7103-b4db-597469de87ed,01a1208d-be62-796a-8f4c-422fc8e15ce4,01a1209e-720b-78e5-bd8c-548bb9e72caa;count=4 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 73154-050
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 73154-050 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 73154-050 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 73154-050 · Verified 2026-10-09 · open in source